brigatinib and its Impurities

Brigatinib acts as both an anaplastic lymphoma kinase (ALK) and epidermal growth factor receptor (EGFR) inhibitor. It is a small molecule targeted cancer therapy being developed by ARIAD Pharmaceuticals, Inc.. Reference standards of Brigatinib API, and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below

Displaying 15 results for brigatinib Impurities
Drug Reference Standards & Impurity Synthesis in India
PA 29 44000

Brigatinib

Brigatinib


  • Catalogue No.:PA 29 44000

  • CAS :

    1197953-54-0

  • Molecular Formula : C29H39ClN7O2P

  • Molecular Weight : 584.09

Drug Reference Standards & Impurity Synthesis in India
PA 29 0441000

2,4-Pyrimidinediamine, 5-chloro-N4-[2-(dimethylphosphinyl)phenyl]-N2-[2-methoxy-4-[4-(1-piperazinyl)-1-piperidinyl]phenyl]

2,4-Pyrimidinediamine, 5-chloro-N4-[2-(dimethylphosphinyl)phenyl]-N2-[2-methoxy-4-[4-(1-piperazinyl)-1-piperidinyl]phenyl]


  • Catalogue No.:PA 29 0441000

  • CAS :

    1197958-75-0

  • Molecular Formula : C28H37ClN7O2P

  • Molecular Weight : 570.07

Drug Reference Standards & Impurity Synthesis in India
PA 29 0441001

N-(5-Chloro-4-((2-(dimethylphosphoryl)phenyl)amino)pyrimidin-2-yl)-N-(2-methoxy-4-(4-(4-methylpiperazin-1-yl)piperidin-1-yl)phenyl)nitrous amide

N-(5-Chloro-4-((2-(dimethylphosphoryl)phenyl)amino)pyrimidin-2-yl)-N-(2-methoxy-4-(4-(4-methylpiperazin-1-yl)piperidin-1-yl)phenyl)nitrous amide


  • Catalogue No.:PA 29 0441001

  • CAS :

    NA

  • Molecular Formula : C29H38ClN8O3P

  • Molecular Weight : 613.1

Drug Reference Standards & Impurity Synthesis in India
PA 29 0441002

N-(5-Chloro-2-((2-methoxy-4-(4-(4-methylpiperazin-1-yl)piperidin-1-yl)phenyl)amino)pyrimidin-4-yl)-N-(2-(dimethylphosphoryl)phenyl)nitrous amide

N-(5-Chloro-2-((2-methoxy-4-(4-(4-methylpiperazin-1-yl)piperidin-1-yl)phenyl)amino)pyrimidin-4-yl)-N-(2-(dimethylphosphoryl)phenyl)nitrous amide


  • Catalogue No.:PA 29 0441002

  • CAS :

    NA

  • Molecular Formula : C29H38ClN8O3P

  • Molecular Weight : 613.1

Drug Reference Standards & Impurity Synthesis in India
PA 29 0441003

N-(5-Chloro-4-((2-(dimethylphosphoryl)phenyl)(nitroso)amino)pyrimidin-2-yl)-N-(2-methoxy-4-(4-(4-methylpiperazin-1-yl)piperidin-1-yl)phenyl)nitrous amide

N-(5-Chloro-4-((2-(dimethylphosphoryl)phenyl)(nitroso)amino)pyrimidin-2-yl)-N-(2-methoxy-4-(4-(4-methylpiperazin-1-yl)piperidin-1-yl)phenyl)nitrous amide


  • Catalogue No.:PA 29 0441003

  • CAS :

    NA

  • Molecular Formula : C29H37ClN9O4P

  • Molecular Weight : 642.1

Drug Reference Standards & Impurity Synthesis in India
PA 29 0441004

5-Methyl Brigatinib

5-Methyl Brigatinib


  • Catalogue No.:PA 29 0441004

  • CAS :

    1197961-02-6

  • Molecular Formula : C30H41ClN7O2P

  • Molecular Weight : 598.13

Drug Reference Standards & Impurity Synthesis in India
PA 29 0441005

5-Chloro-N2,N4-bis(2-methoxy-4-(4-(4-methylpiperazin-1-yl)piperidin-1-yl)phenyl)pyrimidine-2,4-diamine

5-Chloro-N2,N4-bis(2-methoxy-4-(4-(4-methylpiperazin-1-yl)piperidin-1-yl)phenyl)pyrimidine-2,4-diamine


  • Catalogue No.:PA 29 0441005

  • CAS :

    NA

  • Molecular Formula : C38H55ClN10O2

  • Molecular Weight : 719.38

Drug Reference Standards & Impurity Synthesis in India
PA 29 0441006

(2-((5-Chloro-2-((4-(4-hydroxypiperidin-1-yl)-2-methoxyphenyl)amino)pyrimidin-4-yl)amino)phenyl)dimethylphosphine oxide

(2-((5-Chloro-2-((4-(4-hydroxypiperidin-1-yl)-2-methoxyphenyl)amino)pyrimidin-4-yl)amino)phenyl)dimethylphosphine oxide


  • Catalogue No.:PA 29 0441006

  • CAS :

    1197959-30-0

  • Molecular Formula : C24H29ClN5O3P

  • Molecular Weight : 501.95

Drug Reference Standards & Impurity Synthesis in India
PA 29 0441007

2,5-Dichloro-N-(2-methoxy-4-(4-(4-methylpiperazin-1-yl)piperidin-1-yl)phenyl)pyrimidin-4-amine

2,5-Dichloro-N-(2-methoxy-4-(4-(4-methylpiperazin-1-yl)piperidin-1-yl)phenyl)pyrimidin-4-amine


  • Catalogue No.:PA 29 0441007

  • CAS :

    1259274-28-6

  • Molecular Formula : C21H28Cl2N6O

  • Molecular Weight : 451.4

Drug Reference Standards & Impurity Synthesis in India
PA 29 0441008

O-Ethyl Brigatinib

O-Ethyl Brigatinib


  • Catalogue No.:PA 29 0441008

  • CAS :

    1197960-18-1

  • Molecular Formula : C30H41ClN7O2P

  • Molecular Weight : 598.13

Drug Reference Standards & Impurity Synthesis in India
PA 29 0441009

N-(5-Chloro-4-((2-(dimethylphosphoryl)phenyl)amino)pyrimidin-2-yl)-N-(2-methoxy-4-(4-(4-methylpiperazin-1-yl)piperidin-1-yl)phenyl)nitrous amide

N-(5-Chloro-4-((2-(dimethylphosphoryl)phenyl)amino)pyrimidin-2-yl)-N-(2-methoxy-4-(4-(4-methylpiperazin-1-yl)piperidin-1-yl)phenyl)nitrous amide


  • Catalogue No.:PA 29 0441009

  • CAS :

    NA

  • Molecular Formula : C29H38ClN8O3P

  • Molecular Weight : 613.1

Drug Reference Standards & Impurity Synthesis in India
PA 29 0441011

N-(5-Chloro-2-((2-methoxy-4-(4-(4-methylpiperazin-1-yl)piperidin-1-yl)phenyl)amino)pyrimidin-4-yl)-N-(2-(dimethylphosphoryl)phenyl)nitrous amide

N-(5-Chloro-2-((2-methoxy-4-(4-(4-methylpiperazin-1-yl)piperidin-1-yl)phenyl)amino)pyrimidin-4-yl)-N-(2-(dimethylphosphoryl)phenyl)nitrous amide


  • Catalogue No.:PA 29 0441011

  • CAS :

    NA

  • Molecular Formula : C29H38ClN8O3P

  • Molecular Weight : 613.1

Drug Reference Standards & Impurity Synthesis in India
PA STI 090135

Brigatinib D3

Brigatinib D3


  • Catalogue No.:PA STI 090135

  • CAS :

    2055306-71-1

  • Molecular Formula : C29H36D3ClN7O2P

  • Molecular Weight : 587.12

Drug Reference Standards & Impurity Synthesis in India
PA STI 090136

Brigatinib D8

Brigatinib D8


  • Catalogue No.:PA STI 090136

  • CAS :

    2055306-74-4

  • Molecular Formula : C29H31D8ClN7O2P

  • Molecular Weight : 592.15

Drug Reference Standards & Impurity Synthesis in India
PA STI 090137

Brigatinib D11

Brigatinib D11


  • Catalogue No.:PA STI 090137

  • CAS :

    2055306-76-6

  • Molecular Formula : C29H28D11ClN7O2P

  • Molecular Weight : 595.17

pharmaffiliates